Home › Funds › MONTANOVA CAPITAL, LLC › GLUE
MONTANOVA CAPITAL, LLC position in GLUE
MONTE ROSA THERAPEUTICS INC · Health Care
MONTANOVA CAPITAL, LLC reported holding 2,915,944 shares of GLUE (MONTE ROSA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$34.8M, representing 0.81% of its reported portfolio and ranking #34 among its reported holdings. MONTANOVA CAPITAL, LLC has disclosed GLUE holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How MONTANOVA CAPITAL, LLC's GLUE position evolved
MONTANOVA CAPITAL, LLC first disclosed a stake in GLUE in Q2 2024 at 2,659,000 shares (US$9.9M). The position peaked in Q2 2026 at 3,549,539 shares, worth US$85.9M. Across 10 filings, MONTANOVA CAPITAL, LLC increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 2,915,944 shares valued at US$34.8M — a reduction of -633,595 shares quarter over quarter.. Notable position changes include a 41% trim in Q4 2024 (shares fell 33% over the following quarter), a 115% increase in Q2 2025 (shares rose 64% over the following quarter), a 26% increase in Q1 2026 (shares rose 47% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 2.66M | $9.94M | New |
| Q3 2024 | 2.66M | $14.09M | Hold |
| Q4 2024 | 1.56M | $10.85M | Reduce |
| Q1 2025 | 1.56M | $7.26M | Hold |
| Q2 2025 | 3.36M | $15.15M | Add |
| Q3 2025 | 3.36M | $24.90M | Hold |
| Q4 2025 | 3.36M | $52.68M | Hold |
| Q1 2026 | 4.23M | $69.53M | Add |
| Q2 2026 | 3.55M | $85.90M | Reduce |
| Q3 2026 | 2.92M | $34.79M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GLUE and 13F data
GLUE (MONTE ROSA THERAPEUTICS INC) is a Health Care company. 48 other funds we track also report a position in GLUE — the largest reported positions include Vestal Point Capital, LP (US$85.1M), NEA Management Company, LLC (US$79.8M), BAKER BROS. ADVISORS LP (US$51.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GLUE
- Vestal Point Capital, LP 7.13M sh · $85.06M · Q3 2026
- NEA Management Company, LLC 6.69M sh · $79.84M · Q3 2026
- BAKER BROS. ADVISORS LP 4.35M sh · $51.84M · Q3 2026
- BVF INC/IL 4.28M sh · $51.02M · Q3 2026
- TCG Crossover Management, LLC 3.78M sh · $45.11M · Q3 2026
- Versant Venture Management, LLC 3.18M sh · $37.95M · Q3 2026
- BRAIDWELL LP 2.53M sh · $30.14M · Q3 2026
- Aisling Capital Management LP 1.56M sh · $18.56M · Q3 2026
- Opaleye Management Inc. 745.00K sh · $18.03M · Q2 2026
- MPM BioImpact LLC 1.13M sh · $13.42M · Q3 2026
- ADAR1 Capital Management, LLC 1.01M sh · $12.02M · Q3 2026
- Frazier Life Sciences Management, L.P. 1.00M sh · $11.93M · Q3 2026
More on MONTANOVA CAPITAL, LLC
FAQ
How long has MONTANOVA CAPITAL, LLC held GLUE?
MONTANOVA CAPITAL, LLC has disclosed GLUE holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is MONTANOVA CAPITAL, LLC's current position in GLUE?
As of Q3 2026, MONTANOVA CAPITAL, LLC holds 2.92M shares of GLUE (MONTE ROSA THERAPEUTICS INC), valued at $34.79M, representing 0.81% of its reported portfolio and ranking #34.
Has MONTANOVA CAPITAL, LLC been buying or selling GLUE?
In the latest 13F filing (Q3 2026), MONTANOVA CAPITAL, LLC reduced its position in GLUE. The position peaked in Q2 2026 at 3.55M shares.
Which other funds hold GLUE?
Other major institutional holders of GLUE include Vestal Point Capital, LP, NEA Management Company, LLC, BAKER BROS. ADVISORS LP, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.